Posted inBiotechnology
De Novo Design of GPCR Exoframe Modulators
In the ever-evolving landscape of pharmaceutical science, G-protein-coupled receptors (GPCRs) stand as one of the most formidable yet promising therapeutic…
Posted inBiotechnology
T Cell Traits Forecast Lung Cancer Immunotherapy Success
In a groundbreaking study poised to reshape the landscape of immunotherapy for lung cancer, researchers have uncovered a compelling biomarker…
Posted inBiotechnology
Creating Self-Incompatible Hybrid Potatoes via Haploid Breeding
In the relentless pursuit of agricultural innovation, hybrid breeding has long stood as a cornerstone technique for enhancing crop yield…
Posted inBiotechnology
Satellite AI Maps Global Human Development in Detail
A groundbreaking study published in Nature Communications has unveiled a novel approach to measuring the United Nations Human Development Index…
Posted inGenetics
Pancreatic Cancer Cells Sense ECM to Switch Between Growth and Autophagy
Researchers headed by a team at NYU Langone Health have discovered that a feature of pancreatic cancer cells’ surroundings determines…
Posted inBiotechnology
Bacterial and Fungal Infections in Extremely Preterm Infants
In the intricate and profoundly delicate realm of neonatal care, infants born before the threshold of 24 weeks’ gestation represent…
Posted inBiotechnology
Ravn Virus: The Lesser-Known Orthomarburgvirus Explored
In the rapidly evolving field of filovirus research, attention is increasingly turning to the less characterized members of the Orthomarburgvirus…
Posted inBiotechnology
AI Chatbots Use Precise Prompts to Accurately Analyze Big Data
In a groundbreaking exploration of artificial intelligence’s potential to accelerate and enhance the analysis of complex health data, a team…
Posted inGenetics
Turning Microalgae-Derived Extracellular Vesicles Into a Next-Generation Drug Delivery Platform
Paris-based AGS Therapeutics (AGS), which is focused on turning microalgae-derived extracellular vesicles (MEVs) into a next-generation drug delivery platform, signed…
Posted inBiotechnology
Korsana crosses into crowded Alzheimer’s field with $175M and anti-amyloid antibody
A new entrant in the race to shepherd antibodies for Alzheimer’s disease across the blood-brain barrier has emerged. Korsana Biosciences…